The aim of the Swedish competence center Advanced BioProduction by Continuous Processing (AdBIOPRO) affiliated at KTH Royal Institute o Technology is the development of competitive technology for bioproduction, focusing on continuous processes of biopharmaceuticals, and on manufacturing of emerging potent therapeutic products such as recombinant viral vector and cell products. The funding of this competence center has been recently renewed for a period of 5 years until 2027. More details are available on this project at the following weblink: https://www.kth.se/adbiopro.

My contributed work related to this project is the development of identification methods for mammalian cell-kinetics.

Partners: XNK Therapeutics, Cytiva, Valneva, Magic bioprocessing, Karolinska universitetssjukhuset, Cobra:bio, BioInvent sobi, Lunds university.

Related work: Mammalian cell-kinetics identification